Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
Authors
Keywords
-
Journal
CNS SPECTRUMS
Volume 19, Issue S1, Pages 35-53
Publisher
Cambridge University Press (CUP)
Online
2014-11-18
DOI
10.1017/s1092852914000601
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Should cognitive impairment be included in the diagnostic criteria for schizophrenia?
- (2015) RICHARD S.E. KEEFE World Psychiatry
- Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis
- (2014) E. Bora et al. ACTA PSYCHIATRICA SCANDINAVICA
- Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia
- (2014) G. Fervaha et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cognitive Training in Mental Disorders: Update and Future Directions
- (2014) Matcheri S. Keshavan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias
- (2014) S. Jauhar et al. BRITISH JOURNAL OF PSYCHIATRY
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
- (2014) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Impact of primary negative symptoms on functional outcomes in schizophrenia
- (2014) G. Fervaha et al. EUROPEAN PSYCHIATRY
- The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis
- (2014) Gerald Jordan et al. JOURNAL OF CLINICAL PSYCHIATRY
- The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
- (2014) Hui-Ling Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cognitive Remediation Therapy in Adolescents With Early-Onset Schizophrenia: A Randomized Controlled Trial
- (2014) Olga Puig et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study
- (2014) Alp Üçok et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia
- (2014) Helena Fatouros-Bergman et al. SCHIZOPHRENIA RESEARCH
- A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA)
- (2014) Caili Wu et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Motivational Deficits and Cognitive Test Performance in Schizophrenia
- (2014) Gagan Fervaha et al. JAMA Psychiatry
- Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study
- (2013) C. Nordon et al. ACTA PSYCHIATRICA SCANDINAVICA
- Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
- (2013) S. Kristian Hill et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
- (2013) Ann M. Kring et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive remediation improves cognition and good cognitive performance increases time to relapse – results of a 5 year catamnestic study in schizophrenia patients
- (2013) Wolfgang Trapp et al. BMC Psychiatry
- Does cognitive remediation for schizophrenia improve functional outcomes?
- (2013) Alice Medalia et al. CURRENT OPINION IN PSYCHIATRY
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Gender differences in first-episode psychosis at 5-year follow-up – two different courses of disease? Results from the OPUS study at 5-year follow-up
- (2013) A. Thorup et al. EUROPEAN PSYCHIATRY
- New renal anemia drugs: is there really anything new on the horizon?
- (2013) Jolanta Malyszko EXPERT OPINION ON EMERGING DRUGS
- Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis
- (2013) Taro Kishi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: A preliminary open-label trial
- (2013) Hidenobu Suzuki et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Tools to Assess Negative Symptoms in Schizophrenia
- (2013) John M. Kane JOURNAL OF CLINICAL PSYCHIATRY
- Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases
- (2013) Robert A Lasser et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
- (2013) L Fredrik Jarskog et al. NEUROPSYCHOPHARMACOLOGY
- Neural substrates underlying effort computation in schizophrenia
- (2013) Gagan Fervaha et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Subjective Cognitive Complaints in Schizophrenia: Relation to Antipsychotic Medication Dose, Actual Cognitive Performance, Insight and Symptoms
- (2013) William Sellwood et al. PLoS One
- Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis
- (2013) Chuan Shi et al. PSYCHIATRY RESEARCH
- Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis and First-Episode Psychosis: Do the Cognitive Deficits Progress Over, or After, the Onset of Psychosis?
- (2013) E. Bora et al. SCHIZOPHRENIA BULLETIN
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
- (2013) Stephen R. Marder et al. SCHIZOPHRENIA RESEARCH
- Symptom dimensions and functional impairment in early psychosis: More to the story than just negative symptoms
- (2013) Daniel Fulford et al. SCHIZOPHRENIA RESEARCH
- Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care
- (2013) Antonio Vita et al. SCHIZOPHRENIA RESEARCH
- Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: A randomized, double-blind, placebo-controlled study
- (2013) James B. Lohr et al. SCHIZOPHRENIA RESEARCH
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities
- (2013) Jean-Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms
- (2013) Stephen Z. Levine et al. SCHIZOPHRENIA RESEARCH
- Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: A CATIE analysis
- (2013) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Rates and predictors of remission in first-episode schizophrenia within 1year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia
- (2013) Wolfgang Gaebel et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Symptomatic and functional remission in patients with first-episode psychosis
- (2012) S. Verma et al. ACTA PSYCHIATRICA SCANDINAVICA
- Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
- (2012) Xiang Yang Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses
- (2012) Juliano S Souza et al. CNS SPECTRUMS
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives
- (2012) Sara Poletti et al. PSYCHIATRY RESEARCH
- Prevalence of item level negative symptoms in first episode psychosis diagnoses
- (2012) John Lyne et al. SCHIZOPHRENIA RESEARCH
- Estrogen augmentation in schizophrenia: A quantitative review of current evidence
- (2012) Marieke J.H. Begemann et al. SCHIZOPHRENIA RESEARCH
- Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale
- (2012) Gregory P. Strauss et al. SCHIZOPHRENIA RESEARCH
- A brief cognitive–behavioural social skills training for stabilised outpatients with schizophrenia: A preliminary study
- (2012) Mar Rus-Calafell et al. SCHIZOPHRENIA RESEARCH
- Assessing the potential to use neurocognition to predict who is at risk for developing bipolar disorder: A review of the literature
- (2012) Doreen M. Olvet et al. Cognitive Neuropsychiatry
- The Psychosis High-Risk State
- (2012) Paolo Fusar-Poli et al. JAMA Psychiatry
- A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
- (2011) Til Wykes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia
- (2011) Paul M. Grant ARCHIVES OF GENERAL PSYCHIATRY
- Longitudinal Studies of Cognition in First Episode Psychosis: A Systematic Review of the Literature
- (2011) Vasilis P. Bozikas et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Quantifying Clinical Relevance in the Treatment of Schizophrenia
- (2011) Christoph U. Correll et al. CLINICAL THERAPEUTICS
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Validation of a 4-item Negative Symptom Assessment (NSA-4): a short, practical clinical tool for the assessment of negative symptoms in schizophrenia
- (2011) Larry Alphs et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
- Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
- (2011) Carrie K Jones et al. NEUROPSYCHOPHARMACOLOGY
- Negative Symptoms of Schizophrenia as Primary Target of Cognitive Behavioral Therapy: Results of the Randomized Clinical TONES Study
- (2011) S. Klingberg et al. SCHIZOPHRENIA BULLETIN
- Social Cognition as a Mediator Variable Between Neurocognition and Functional Outcome in Schizophrenia: Empirical Review and New Results by Structural Equation Modeling
- (2011) S. J. Schmidt et al. SCHIZOPHRENIA BULLETIN
- Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
- (2011) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial
- (2011) William V. Bobo et al. SCHIZOPHRENIA RESEARCH
- Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study
- (2011) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- The “Anhedonia Paradox” in Schizophrenia: Insights from Affective Neuroscience
- (2010) Diego A. Pizzagalli BIOLOGICAL PSYCHIATRY
- Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis
- (2010) Surendra P. Singh et al. BRITISH JOURNAL OF PSYCHIATRY
- Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder
- (2010) Michael S. Ritsner et al. JOURNAL OF CLINICAL PSYCHIATRY
- Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
- (2010) Emmanuel Pinard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study
- (2010) O. Grynszpan et al. PSYCHOLOGICAL MEDICINE
- The Brief Negative Symptom Scale: Psychometric Properties
- (2010) Brian Kirkpatrick et al. SCHIZOPHRENIA BULLETIN
- The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?
- (2010) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Initial development and preliminary validation of a new negative symptom measure: The Clinical Assessment Interview for Negative Symptoms (CAINS)
- (2010) Courtney Forbes et al. SCHIZOPHRENIA RESEARCH
- The Cognitive Assessment Interview (CAI): Development and validation of an empirically derived, brief interview-based measure of cognition
- (2010) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
- The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study
- (2010) Robert S. Kern et al. SCHIZOPHRENIA RESEARCH
- Cognition at illness onset as a predictor of later functional outcome in early psychosis: Systematic review and methodological critique
- (2010) Kelly Allott et al. SCHIZOPHRENIA RESEARCH
- Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
- (2010) Richard S.E. Keefe et al. SCHIZOPHRENIA RESEARCH
- A Randomized, Controlled Trial of Computer-Assisted Cognitive Remediation for Schizophrenia
- (2009) Dwight Dickinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study
- (2009) Emre Bora et al. BRITISH JOURNAL OF PSYCHIATRY
- Deficit schizophrenia: An overview of clinical, biological and treatment aspects
- (2009) S. Galderisi et al. EUROPEAN PSYCHIATRY
- A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia
- (2009) Robert H. Pietrzak et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice
- (2009) Julio Bobes et al. JOURNAL OF CLINICAL PSYCHIATRY
- Short-Term Testosterone Augmentation in Male Schizophrenics
- (2009) Young-Hoon Ko et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cognitive deficits in recent-onset and chronic schizophrenia
- (2009) S.R. Sponheim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neurocognition in first-episode schizophrenia: A meta-analytic review.
- (2009) Raquelle I. Mesholam-Gately et al. NEUROPSYCHOLOGY
- A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians
- (2009) I. M. Hurford et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
- (2009) L. B. Dixon et al. SCHIZOPHRENIA BULLETIN
- Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond
- (2009) E. Bora et al. SCHIZOPHRENIA BULLETIN
- Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study
- (2009) Silvana Galderisi et al. SCHIZOPHRENIA RESEARCH
- Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
- (2008) Anantha Shekhar et al. AMERICAN JOURNAL OF PSYCHIATRY
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
- (2008) G. Foussias et al. SCHIZOPHRENIA BULLETIN
- Emotional Experience in Patients With Schizophrenia Revisited: Meta-analysis of Laboratory Studies
- (2008) A. S. Cohen et al. SCHIZOPHRENIA BULLETIN
- Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder
- (2008) Jean-Marc Chianetta et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects
- (2008) Eri Nakagami et al. SCHIZOPHRENIA RESEARCH
- Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial
- (2008) Shahin Akhondzadeh et al. SCHIZOPHRENIA RESEARCH
- Clinical global impression of cognition in schizophrenia (CGI-CogS): Reliability and validity of a co-primary measure of cognition
- (2007) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More